Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.690
0.00 (0.00%)
At close: Sep 5, 2025, 4:00 PM
1.720
+0.030 (1.78%)
After-hours: Sep 5, 2025, 6:52 PM EDT
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $72.60 million as of September 5, 2025. Its market cap has decreased by -44.82% in one year.
Market Cap
72.60M
Enterprise Value
-36.22M
1-Year Change
-44.82%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $72.60M, a decrease of -92.32%. That is a compound annual growth rate of -38.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 72.60M | 30.37% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | 1.26B | 33.34% |
| Jun 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |